Effects of Nerve Block on Knee Function After Knee Replacement
NCT ID: NCT00358241
Last Updated: 2020-05-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Continuous Adductor Canal Blocks Vs. Low Dose Femoral Nerve Blocks For Early Rehabilitation After Total Knee Arthroplasty
NCT02453321
Analgesic Efficacy of Saphenous Nerve Blockade for Outpatient Knee Anterior Cruciate Ligament Surgery
NCT02071433
Obturator Nerve Block With Femoral and Sciatic Block
NCT01409460
Adductor Canal Block Versus Femoral Nerve Block for Total Knee Arthroplasty
NCT03133481
Continuous Femoral Nerve Block Following Total Knee Replacement
NCT00135889
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nerve block
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA Physical Status ASA I and II
* Mentally competent
* Intellectually competent
* Body mass index \<35
* No severe cardiac diseases
* No severe pulmonary diseases
* Unilateral knee disease
* No other lower extremity joint disease
* No chronic narcotic therapy or illicit drug use
Exclusion Criteria
* ASA Physical Status \>ASA II
* Mentally incompetent
* Intellectually incompetent or cognitively impaired
* Non-English speaking patient
* Worker's compensation patient
* Body mass index \> 35
* Bilateral knee disease
* Has other lower extremity joint disease
* Severe cardiac diseases
* Severe pulmonary diseases
* Chronic narcotic therapy or illicit drug use
* Pregnancy
21 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johns Hopkins University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
J Hang, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Johns Hopkins Medicine, Johns Hopkins University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Johns Hopkins Bayview Medical Center
Baltimore, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
04-03-05-05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.